网络出版日期: 2023-01-25
基金资助
河北省财政厅资助临床医学优秀人才项目基金 (编号:〔2020〕23 号)
Research progress of new hypoglycemic drugs in the treatment of type 2 diabetes
Clinical Medical College of Hebei University of Engi⁃ neering,Handan 056000,China
Online published: 2023-01-25
杨燕 卓见 申红霞 韩瑞敏 王珍 王德峰 . 新型降糖药物治疗2型糖尿病的研究进展[J]. 实用医学杂志, 2023 , 39(2) : 153 -157 . DOI: 10.3969/j.issn.1006⁃5725.2023.02.005
The morbidity and mortality of diabetes have increased rapidly in recent years. The drugs aim⁃ ing to act on new targets to control type 2 diabetes mellitus(T2DM)is not uncommon. At present,12 different types of anti⁃diabetic drugs are available to be used,offering various treatment measures through all aspects of the mechanism of diabetes. As compared with traditional drugs,new hypoglycemic drugs are safer and more effective, and have a protective effect on heart and kidney,delaying the occurrence of diabetic complications. This article reviews the current drugs acting at new targets for the treatment of T2DM in order to provide guidance for clinical treatment of T2DM.
Key words:
type 2 diabetes
/
| 〈 |
|
〉 |